What are the recommended antibiotic choices and dosages for acute bacterial sinusitis in adults and children, including options for penicillin-allergic or pregnant patients?

Antibiotic Treatment for Sinus Infection

For adults with acute bacterial sinusitis, amoxicillin-clavulanate 875 mg/125 mg twice daily for 5–10 days is the first-line antibiotic, providing 90–92% predicted clinical efficacy against the major pathogens. 1

Confirming the Diagnosis Before Prescribing

Before initiating antibiotics, you must confirm acute bacterial rhinosinusitis (ABRS) by meeting at least one of three clinical patterns:

• Persistent symptoms ≥10 days with purulent nasal discharge plus either nasal obstruction or facial pain/pressure/fullness 1
• Severe symptoms ≥3–4 consecutive days with fever ≥39°C, purulent discharge, and facial pain 1
• "Double sickening": initial improvement from a viral URI followed by worsening within 10 days 1

Critical context: Approximately 98–99.5% of acute rhinosinusitis cases are viral and resolve spontaneously within 7–10 days without antibiotics. 1 Do not prescribe antibiotics for symptoms <10 days unless the severe criteria above are met. 1

First-Line Antibiotic Regimen

Standard Dosing (Most Patients)

• Amoxicillin-clavulanate 875 mg/125 mg orally twice daily for 5–10 days (or until symptom-free for 7 consecutive days, typically 10–14 days total) 1
• This regimen achieves 90–92% predicted efficacy against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 1
• The clavulanate component is essential because 30–40% of H. influenzae and 90–100% of M. catarrhalis produce β-lactamase 1

High-Dose Regimen (Risk Factors Present)

Use amoxicillin-clavulanate 2 g/125 mg twice daily when any of these risk factors are present: 1

• Recent antibiotic use (within past 4–6 weeks)
• Age >65 years
• Daycare exposure
• Moderate-to-severe symptoms
• Comorbidities (diabetes, chronic cardiac/hepatic/renal disease)
• Immunocompromised state

Shorter Course Evidence

Recent data support 5–7 day courses as equally effective with fewer adverse effects compared to traditional 10-day regimens. 1 However, continue until symptom-free for 7 consecutive days to prevent relapse. 1

Alternatives for Penicillin Allergy

Non-Severe (Mild Rash, Delayed Reaction)

• Second- or third-generation cephalosporins for 10 days: cefuroxime-axetil, cefpodoxime-proxetil, cefdinir, or cefprozil 1
• Cross-reactivity with penicillins is <1%, making these safe alternatives 1

Severe (Type I/Anaphylactic) Allergy

• Levofloxacin 500 mg once daily for 10–14 days OR Moxifloxacin 400 mg once daily for 10 days 1
• Both achieve 90–92% predicted efficacy against multidrug-resistant S. pneumoniae and β-lactamase-producing organisms 1
• Reserve fluoroquinolones for severe allergy or documented treatment failure to limit resistance development 1

Suboptimal Alternative (When Fluoroquinolones Contraindicated)

• Doxycycline 100 mg once daily for 10 days offers lower efficacy (77–81%) with a 20–25% bacteriologic failure rate due to limited H. influenzae coverage 1
• Contraindicated in children <8 years due to tooth enamel discoloration 1

Antibiotics to Avoid

• Macrolides (azithromycin, clarithromycin): 20–25% resistance rates in S. pneumoniae and H. influenzae make them unsuitable 1
• Trimethoprim-sulfamethoxazole: ≈50% resistance in S. pneumoniae and ≈27% in H. influenzae 1
• First-generation cephalosporins (cephalexin): inadequate because ≈50% of H. influenzae strains produce β-lactamase 1

Essential Adjunctive Therapies (Add to All Patients)

• Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and accelerate symptom resolution—supported by strong evidence from multiple randomized controlled trials 1
• Saline nasal irrigation 2–3 times daily provides symptomatic relief and aids mucus clearance 1
• Analgesics (acetaminophen or ibuprofen) for pain and fever control 1

Watchful Waiting Strategy

For uncomplicated ABRS with reliable follow-up, initial observation without antibiotics is appropriate. 1 Initiate antibiotics only if:

• No improvement by day 7 OR
• Symptoms worsen at any time 1

The number needed to treat (NNT) with antibiotics is 10–15 to achieve one additional cure compared to placebo, reflecting the high spontaneous recovery rate. 1

Monitoring and Reassessment Protocol

Early Reassessment (Days 3–5)

• If no clinical improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch to high-dose amoxicillin-clavulanate or a respiratory fluoroquinolone 1
• Do not extend the initial antibiotic beyond 3–5 days without improvement 1

Day 7 Reassessment

• Persistent or worsening symptoms require: 1
  • Confirmation of ABRS diagnosis
  • Exclusion of complications (orbital cellulitis, meningitis, intracranial abscess)
  • Imaging (CT) only if complications are suspected
  • Referral to ENT when appropriate

Expected Recovery Timeline

• Noticeable improvement should occur within 3–5 days of appropriate therapy 1
• Complete resolution typically by 10–14 days or when symptom-free for 7 consecutive days 1

Referral to Otolaryngology

Refer immediately for any of the following: 1

• No improvement after 7 days of appropriate second-line antibiotic therapy
• Worsening symptoms at any point (increasing facial pain, fever, purulent drainage)
• Signs of complications: severe headache, visual changes, periorbital swelling/erythema, proptosis, diplopia, altered mental status, cranial nerve deficits
• Recurrent sinusitis (≥3 episodes per year) requiring evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities

Pediatric Considerations

Standard Dosing

• Amoxicillin 45 mg/kg/day divided twice daily for children ≥3 months with uncomplicated disease 1

High-Risk Children

Use amoxicillin 80–90 mg/kg/day divided twice daily for: 1

• Age <2 years
• Daycare attendance
• Antibiotic use within past 4–6 weeks
• High local resistance rates

High-Dose Amoxicillin-Clavulanate

• 80–90 mg/kg/day (amoxicillin component) with 6.4 mg/kg/day clavulanate divided twice daily 1

Treatment Duration

• Minimum 10–14 days for children (longer than adult courses) 1
• Reassess at 72 hours; if no improvement, switch to high-dose amoxicillin-clavulanate 1

Common Pitfalls to Avoid

• Gastrointestinal adverse effects with amoxicillin-clavulanate are common: diarrhea in 40–43% of patients, severe diarrhea in 7–8% 1
• Do not obtain routine imaging (X-ray or CT) for uncomplicated ABRS; up to 87% of viral URIs show sinus abnormalities on imaging, leading to unnecessary interventions 1
• Ensure adequate treatment duration (≥5 days for adults, ≥10 days for children) to prevent relapse 1
• Fluoroquinolones should not be used as first-line therapy in patients without documented β-lactam allergy to limit resistance development 1

Special Situations

Pregnancy

• Penicillin and cephalosporins are the safest classes and can be given when endoscopic evidence of purulence is present 2
• Antibiotics that put the fetus at risk (tetracyclines, aminoglycosides, trimethoprim-sulfamethoxazole, fluoroquinolones) should not be used during pregnancy 2

Treatment Failure After Amoxicillin-Clavulanate

• Switch to levofloxacin 500 mg once daily for 10–14 days or moxifloxacin 400 mg once daily for 10 days 1
• These provide 90–92% predicted efficacy against drug-resistant S. pneumoniae and β-lactamase-producing organisms 1